secwatch.observer — SEC 8-K summary
======================================

Issuer:     Integer Holdings Corp (ITGR)
CIK:        0001114483
Form:       8-K
Filed at:   2025-07-10T23:59:59+00:00
Accession:  0001171843-25-004406
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integer appoints Michael Coyle to Board; brings 40+ years medtech leadership
----------------------------------------------------------------------------

- Michael Coyle appointed to Integer's Board of Directors effective July 10, 2025.
- Coyle most recently served as president/CEO of iRhythm Technologies; prior roles at Medtronic, St. Jude Medical, and Eli Lilly.
- He will serve on Audit, Compensation & Organization, and Technology Strategy Committees.
- Board size increased to 11 directors; Coyle's term runs until next annual meeting.
- Coyle holds a Wharton MBA and six U.S. patents related to cardiovascular medical devices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1114483/000117184325004406/0001171843-25-004406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1114483/000117184325004406/f8k_071025.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-004406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer